Navigation Links
JDRF Announces New Outreach Kit to Support Adults Newly Diagnosed with Type 1 Diabetes
Date:4/15/2013

NEW YORK, April 15, 2013 /PRNewswire-USNewswire/ -- JDRF announced today that it has created a new resource for adults newly diagnosed with type 1 diabetes (T1D). The Adult Type 1 Pak is a sling-style bag that will include important resources and information to educate, support, and inspire adults newly diagnosed with T1D, age 16 and above. In collaboration with JDRF's generous sponsors—Bayer Healthcare, Medtronic, and Novo Nordisk—the kit is now available through local JDRF chapters, and is free of charge.

(Photo:  http://photos.prnewswire.com/prnh/20130415/DC94365 )

The Adult Type 1 Pak was created as a part of an effort to ensure that all individuals newly diagnosed with T1D receive the information and support necessary to adjust to life with the disease. JDRF has found the Bag of Hope to be extremely beneficial to families of newly-diagnosed children with T1D, and is hopeful that the Adult Type 1 Pak will be just as valuable to newly-diagnosed adults. Each year in the United States alone, more than 15,000 children and 15,000 adults are diagnosed with T1D, and JDRF continues to work to expand its efforts to better support people of all ages, and at all stages of life with the disease.

"JDRF is wholeheartedly committed to all people with type 1 diabetes, and adults make up 85 percent of that population," said Jeffrey Brewer , president and CEO of JDRF. "Adults who are newly diagnosed face challenges that are very different from children who are newly diagnosed, and we are proud to be able to offer this resource to help them take charge of their lives in the midst of such a huge transition. Most importantly, we want these adults to know that they have a network of support through JDRF and that amazing progress is being made in type 1 diabetes research. We're grateful to Bayer Healthcare, Medtronic, and Novo Nordisk for their support of the Adult Type 1 Pak."

Newly-diagnosed adults with T1D can contact their local JDRF chapters for the Adult Type 1 Pak, and for more information on ways to get involved with JDRF and the T1D community.

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF's goal is to progressively remove the impact of T1D from people's lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.

As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF's expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization's efficiency and effectiveness.

For more information, please visit jdrf.org.


'/>"/>
SOURCE JDRF
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioRestorative Therapies Announces One-for-Fifty Reverse Stock Split
2. ORTHOWORLD(R) Announces FDA Official to Serve as Panelist at Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC(R))
3. Sony Announces First East and West Coast Installations of 3D Imaging Solution for Ophthalmic Surgery
4. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
5. Northstar announces that its much-anticipated pet healthcare product will go on sale April 17th
6. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
7. Green Valley Drugs Announces Voluntary Nationwide Recall Of All Lots Of All Sterile Products Compounded, Repackaged, And Distributed By Green Valley Drugs Due To Quality Control Concerns
8. NASP Announces Jim Smeeding, RPh, MBA, as Executive Director
9. Andain Inc. Announces Successful 510K Tests of its Breakthrough Miniature Disposable Insulin Pump
10. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
11. CryoLife Announces Release Date and Teleconference Call Details for 2013 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... CITY, Mo. , May 3, 2016 /PRNewswire/ ... Kansas Medical Center,s Institute for Advancing Medical Innovation ... and commercialize new drugs, diagnostics and medical devices. ... provides BioNovus Innovations with rights to license, develop ... "This partnership represents ...
(Date:5/3/2016)... , May 3, 2016  As a teenager, an ... rheumatic fever, which damaged his heart. He continued enjoying ... by June 2013, Shepherd,s heart was giving out and ... On June 20, 2013, the Mesa, Arizona ... Heart (TAH-t). Like a heart transplant, the SynCardia TAH-t ...
(Date:5/3/2016)...  While you may be familiar with watching a film or TV show in high definition, ... 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of the medical industry,s ... - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... 05, 2016 , ... Chronic stress can have a silent, yet dangerous, impact ... immune system and increase inflammation, both of which raise the risk of heart attack ... disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can lead to other ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... honored finalists and winners Tuesday evening, May 3, at the 2016 ISE® Central ... , Scott Pettigrew, Vice President and Chief Security Officer of HMS, was selected ...
(Date:5/5/2016)... , ... May 05, 2016 , ... If you don’t ... marks on your skin, you may want to consider a treatment that some have ... Advanced Dermatology P.C. , Microneedling, also known as skin needling, is a ...
(Date:5/5/2016)... Austin, TX (PRWEB) , ... May 05, 2016 , ... ... existence to offer the breakthrough technology of the new PiQo4™ laser, the first 4-wavelenth ... treating more tattoo inks than any other picosecond laser on the market. Jeremy ...
(Date:5/5/2016)... ... 05, 2016 , ... Liposuction specialist Marcia V. Byrd, MD spoke last month ... the Marriot St. Louis Airport Hotel. This year’s conference was titled “Living with Lipedema ... her unique specialization in treating Lipedema. Dr. Byrd is considered one of the leading ...
Breaking Medicine News(10 mins):